Bisbibenzyls, novel proteasome inhibitors, suppress androgen receptor transcriptional activity and expression accompanied by activation of autophagy in prostate cancer LNCaP cells

Emerging Role of the Ubiquitin-proteasome System as Drug Targets

(2013) Gozde Kar et al.   CURRENT PHARMACEUTICAL DESIGN

Role of Ubiquitin Ligases and the Proteasome in Oncogenesis: Novel Targets for Anticancer Therapies

(2013) Lindsey N. Micel et al.   JOURNAL OF CLINICAL ONCOLOGY

Androgen deprivation and androgen receptor competition by bicalutamide induce autophagy of hormone-resistant prostate cancer cells and confer resistance to apoptosis

(2013) Benoît Boutin et al.   PROSTATE

Marchantin M: a novel inhibitor of proteasome induces autophagic cell death in prostate cancer cells

(2013) H Jiang et al.   Cell Death & Disease

P53 and the proteasome regulate androgen receptor activity

(2012) Natalya V. Guseva et al.   CANCER BIOLOGY & THERAPY

The androgen/androgen receptor axis in prostate cancer

(2012) Eric G. Bluemn et al.   CURRENT OPINION IN ONCOLOGY

Targeting Androgen Receptor Leads to Suppression of Prostate Cancer via Induction of Autophagy

(2012) Qi Jiang et al.   JOURNAL OF UROLOGY

Cyclic bisbibenzyls induce growth arrest and apoptosis of human prostate cancer PC3 cells

(2010) Ai-hui Xu et al.   ACTA PHARMACOLOGICA SINICA

The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process

(2010) Pierre Chymkowitch et al.   EMBO JOURNAL

Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II

(2010) Xia Xue et al.   INVESTIGATIONAL NEW DRUGS

Drug resistance in metastatic castration-resistant prostate cancer

(2010) Bostjan Seruga et al.   Nature Reviews Clinical Oncology

Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells

(2009) K Zhu et al.   ONCOGENE

Inhibitory effect of acetyl-11-keto-β-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells

(2008) Hui-Qing Yuan et al.   BIOCHEMICAL PHARMACOLOGY

Marchantin C, a macrocyclic bisbibenzyl, induces apoptosis of human glioma A172 cells

(2008) Yan-Qiu Shi et al.   CANCER LETTERS

Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro

(2008) Yan-qiu Shi et al.   CANCER LETTERS

Androgen receptor and growth factor signaling cross-talk in prostate cancer cells

(2008) M.-L. Zhu et al.   ENDOCRINE-RELATED CANCER